Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005296786 | SCV005961405 | uncertain significance | not specified | 2024-12-11 | criteria provided, single submitter | clinical testing | The c.1202A>G (p.N401S) alteration is located in exon 9 (coding exon 9) of the AXL gene. This alteration results from a A to G substitution at nucleotide position 1202, causing the asparagine (N) at amino acid position 401 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |